PLPLENEN

Menstruation and Contraception on a High-Altitude Expedition

Autor

Agnieszka Wiernik

5 min czytania

Menstruation and contraception on a high-altitude expedition is a rarely discussed topic — but for women planning treks in the Himalayas, Andes, or Africa, it is a real logistical and medical problem. Two key questions: how to manage the cycle without running water or sanitation, and whether hormonal contraception raises thrombosis risk at altitude. This article: specific answers, pharmacological decisions, and practical solutions.

In a nutshell

  • Combined contraception (estrogen + progestin) at altitude = 3–4× higher risk of venous thrombosis. Consider switching 3 months before expedition.
  • Progestin-only (mini-pills, Mirena IUD, implants) do not raise thrombosis risk — safe on expedition.
  • Cycle deferral through continuous combined contraception is an option for short trips (1–2 months) but requires gynecologist consultation.
  • Menstrual cup is a practical solution on expedition without sanitation — 8–12 h between changes.
  • Insomnia and low mood in luteal phase are amplified by altitude — plan summit push in first half of cycle if possible.

Altitude + estrogen = increased thrombosis risk

Mechanism of deep vein thrombosis (DVT) and pulmonary embolism (PE) at altitude rests on Virchow’s triad (endothelial injury, blood stasis, hypercoagulability). Altitude provides all three factors:

  • Polycythemia — hematocrit rises from 40% to 50–55% after 2 weeks at 5000 m; blood is “thicker”
  • Dehydration — despite 3–6 L/day recommendations, most trekkers are in mild fluid deficit
  • Immobilization — long flights to Nepal/Peru, lodge sitting, tent nights
  • Endothelial injury — hypoxia activates inflammatory factors damaging endothelium

Combined oral contraception adds 3× higher baseline DVT risk (already off-altitude). Combining both factors gives estimated 7–10× higher risk compared to non-contraceptive users at sea level. At extreme altitudes (>5500 m) there are case reports of DVT in patients using combined contraception — rare, but real.

Recommendations for specific contraceptive methods

Combined oral contraception (estrogen + progestin)

  • Expeditions <2 weeks, altitude <4000 m: low risk, can continue
  • Expeditions 2–4 weeks, altitude 4000–5500 m: consider temporary switch to progestin-only 3 months before
  • Expeditions >4 weeks or >5500 m (Everest BC, Aconcagua, Denali): stop combined contraception for expedition, switch to progestin-only or IUD
  • After return: combined hormones can be resumed after 4–6 weeks (when hematocrit returns to normal)

Progestin-only (“mini-pills” — desogestrel, norethisterone)

Safe at altitude. No significant clotting impact. However, they require strict dosing schedule (same time +/- 3 hours for desogestrel, +/- 12 h for norethisterone). On expedition with jet lag and time zone changes, maintaining schedule is hard — consider a wristwatch alarm.

Hormonal IUD (Mirena, Kyleena, Jaydess)

Ideal for expedition. No systemic estrogen, constant local uterine hormone concentration, no daily dosing needed. Additional benefit: in 20–50% of women menstruation stops completely after 6–12 months — significantly simplifies 3-week expedition logistics. Optimally inserted 3–6 months before expedition (allows time for adaptation and potential bleeding irregularity).

Copper IUD (non-absorbable)

No clotting impact. But often amplifies menstrual bleeding by 20–30% — can be a logistical problem on long expedition. For short treks OK; for 3–4 week expeditions consider hormonal IUD.

Subdermal implant (Implanon, Nexplanon)

Progestin-only, no estrogen. Safe at altitude. Insertion 3 months before expedition. Some women experience irregular bleeding — inconvenient on expedition but not dangerous.

Cycle deferral for the expedition

Continuous combined contraception

Skip the 7-day pause between packs — take next pack immediately. Result: no menstrual bleeding. Medically safe for 3–6 months. Pre-expedition gynecologist consultation essential.

Short-term norethisterone

Norethisterone 5 mg three times daily, started 3 days before expected period. Delays cycle up to 3–4 weeks. No thrombosis risk (pure progestin). Period arrives 2–3 days after stopping. Most flexible option for 2–4 week expeditions without ongoing contraception.

Menstruation on expedition — logistics

Menstrual cup

  • Silicone cup worn 8–12 h (vs tampon 4–6 h)
  • No running water needed for emptying (toilet or snow aside suffices)
  • Sterilized before expedition in boiling water, rinsed with mineral water on trip
  • Cost: 30–50 EUR, reusable for 10 years
  • Requires practice — train 2–3 months before expedition

Period underwear (Thinx, Modibodi, Knixwear)

  • Layered absorbent technology — no tampons or pads
  • Hand washing, drying in tent overnight
  • 3–4 pairs for expedition (rotation every 8–12 h)
  • Cost: 30–40 EUR/pair, durable

Tampons and pads

  • Classic option but generates waste (pack out in sealed bags — leave-no-trace principle)
  • For 3-week expedition: 40–60 tampons + 20 pads = 150–200 g of gear
  • In destination countries (Nepal, India, Peru) availability is limited — bring from home

Cycle and physical performance at altitude

Cycle phase affects performance and wellbeing — data from endurance athletes suggests:

  • Follicular phase (days 1–14) — better aerobic exercise tolerance, faster recovery
  • Luteal phase (days 15–28) — elevated body temperature, more fatigue, insomnia, mood swings — amplified by altitude
  • Premenstrual syndrome (PMS) — headache, edema, irritability — may be misattributed to AMS
  • First 2 days of menstruation — severe abdominal pain, blood loss, weakness

Practical recommendation: if planning an expedition with one rigid summit window, try to schedule summit push for the follicular phase. For a 3-week expedition with flexible schedule — less important, cycle will be regulated by altitude evacuation anyway.

Frequently asked questions

Do I need to stop contraception before Kilimanjaro?

For standard 7-day Kilimanjaro expedition (max 5895 m) DVT risk with combined contraception is moderate but real. My recommendation: 1) if expedition >7 days and other risk factors (smoking, BMI >30, age >35) — yes, stop 3 months before; 2) if standard 5-7 day expedition without additional risk factors — continue but aggressively hydrate, avoid long lodge immobilization, consider aspirin 100 mg/day as prophylaxis.

Is Mirena IUD safe on Everest BC trip?

Yes, Mirena is one of the safest contraceptive options on expedition. No systemic estrogen = no increased thrombosis risk. Bonus benefit: after 6-12 months of use, 20-50% of women experience complete menstrual cessation — eliminating logistical problem on 3-week expedition. Optimally inserted 6 months before expedition to allow body adaptation.

Will a menstrual cup freeze in the tent?

Silicone used in menstrual cups (Lunette, Mooncup, DivaCup) is stable -50°C to +250°C. Freezing doesn’t damage the cup. In expedition practice: cup used internally has body temperature, when emptying — 5-10 min frost doesn’t harm it, warms back to elastic state in hand.

How to manage severe menstrual pain on expedition?

NSAIDs first choice: ibuprofen 400-600 mg every 8 h (better than paracetamol for dysmenorrhea — inhibits prostaglandin synthesis). Start NSAIDs 1-2 days before expected period if regularly painful. Heat on abdomen (chemical warmers in sleeping bag waist). If needed — add paracetamol 1000 mg every 6 h. For severe pain unresponsive to NSAIDs — consider opioid (tramadol 50-100 mg if in kit). Menstrual pain is NOT grounds for abandoning expedition, pharmacologically manageable.

Can luteal phase fatigue be confused with AMS?

Yes, and this is a significant diagnostic pitfall. Luteal phase symptoms (fatigue, insomnia, mood swings, elevated body temperature, headache) largely overlap with AMS symptoms. Key to differentiation: AMS resolves after 24-48 h rest at same altitude and responds to ibuprofen; luteal phase persists about 14 days and responds to… time, until menstruation begins. Pulse oximeter helps — in AMS saturation is low, in luteal phase normal.

References

  • Jochberger S, Fries D, Pinggera GM. Thromboembolic events in hormonal contraception. Thromb Res. 2011;127(Suppl 3):S52–55.
  • Schreiber J. Contraception and altitude. Travel Medicine and Infectious Disease. 2015;13(6):447–451.
  • Jean D, Leal C, Kriemler S, et al. Medical recommendations for women going to altitude. High Alt Med Biol. 2005;6(1):22–31.

Disclaimer: Contraceptive changes require gynecologist consultation minimum 3 months before expedition. This article is informational. For severe chest pain or limb swelling on expedition — call emergency services urgently.